DOW JONES NEWSWIRES

GPC Biotech's (NASDAQ-NMS:GPCB) (GPCB) fourth-quarter loss narrowed to EUR11.9 million, or EUR0.32 a share, from EUR17.2 million, or EUR0.51 a share, in the prior-year period.

The Munich-based biotechnology company's revenue fell to EUR2.17 million from EUR5.09 million last year.

(Headlines published at 2:37 a.m. EDT incorrectly stated the total loss per- share figures)

    (END) Dow Jones Newswires   03-27-08 0308   Copyright (c) 2008 Dow Jones & Company, Inc.